Safety Facts about Dynamiclear
Download the full Consumer Medicine Information leaflet for detailed safety advice regarding Dynamiclear.
The effectiveness and safety of Dynamiclear is published in the Journal of Drugs and Dermatology. The New York based Journal of Drugs in Dermatology, one of the most credible sources for new medical developments in the field of skin care, published early in 2012 that:
“The Dynamiclear formulation was well tolerated, and efficacy was demonstrated in a number of measured parameters, which are helpful in the symptomatic management of HSV-1 and HSV-2 lesions in adult patients. Remarkably, the effects seen from this product came from a single application.”
More information on the Peer Reviewed Phase III Dynamiclear Clinical Trial
Dynamiclear is manufactured in a Pharmaceutical GMP Certified Laboratory. In addition to Dynamiclear being registered as a TGA listed medicine it is also manufactured in a Pharmaceutical Good Manufacturing Practice (GMP) compliant laboratory that is independently inspected for Sanitary, Quality Control and Safety.
GMP Certification is a strict health code that is recognized by health industries in the United States, Canada, Australia, Japan, the UK, Europe and other countries. The application of GMP standards guarantees the quality, hygiene and consistency of all of the batches that Dynamiclear produce.